Arcellx Correlations
ACLX Stock | USD 69.87 2.87 3.95% |
The current 90-days correlation between Arcellx and Nuvalent is 0.38 (i.e., Weak diversification). The correlation of Arcellx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Arcellx Correlation With Market
Average diversification
The correlation between Arcellx and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and DJI in the same portfolio, assuming nothing else is changed.
Arcellx |
Moving together with Arcellx Stock
0.77 | VERA | Vera Therapeutics | PairCorr |
0.85 | DSGN | Design Therapeutics | PairCorr |
0.72 | VINC | Vincerx Pharma | PairCorr |
0.85 | VKTX | Viking Therapeutics | PairCorr |
0.68 | VTYX | Ventyx Biosciences | PairCorr |
Moving against Arcellx Stock
0.66 | DMAC | DiaMedica Therapeutics | PairCorr |
0.64 | VALN | Valneva SE ADR | PairCorr |
0.61 | VIGL | Vigil Neuroscience | PairCorr |
0.5 | VERV | Verve Therapeutics | PairCorr |
0.35 | EQ | Equillium | PairCorr |
0.74 | VRNA | Verona Pharma PLC | PairCorr |
0.57 | SRZNW | Surrozen Warrant | PairCorr |
0.37 | VTVT | vTv Therapeutics Trending | PairCorr |
0.36 | EDSA | Edesa Biotech | PairCorr |
0.34 | VSTM | Verastem | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Arcellx Stock performing well and Arcellx Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Arcellx's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NUVL | 2.17 | (0.19) | 0.00 | (0.30) | 0.00 | 3.54 | 12.24 | |||
VTYX | 3.63 | (1.09) | 0.00 | (17.50) | 0.00 | 6.88 | 27.07 | |||
AMLX | 3.82 | (0.17) | 0.00 | (0.21) | 0.00 | 7.20 | 21.45 | |||
DAWN | 2.78 | (0.52) | 0.00 | (0.71) | 0.00 | 6.36 | 22.86 | |||
BMEA | 3.87 | (0.92) | 0.00 | (0.51) | 0.00 | 6.48 | 27.28 |
Arcellx Corporate Management
Michael MBA | Chief Officer | Profile | |
Aileen Fernandes | Chief Officer | Profile | |
Kate Aiken | Chief Officer | Profile | |
Michelle Gilson | Chief Officer | Profile | |
Myesha Lacy | Chief Officer | Profile | |
Christopher MD | Chief Officer | Profile | |
MS JD | General Counsel | Profile |